January 2013- Volume 9, Issue 1

January 2013

In this Issue

Diagnostics

Catching something in China

Catching something in China

PerkinElmer acquires China-based infectious disease diagnostics company Shanghai Haoyuan Biotech

The sooner the diagnosis, the better the outcome

The sooner the diagnosis, the better the outcome

Boston Children’s Hospital develops new blood test for early diagnosis of autism

Highly personalized medicine

Highly personalized medicine

Galena and Leica develop companion diagnostic for breast cancer therapeutic

PROOF for FFPE samples

PROOF for FFPE samples

HTG Molecular Diagnostics and PROOF Centre partner to commercialize COPD prognostic test

Global News

Consortium of binding interactions

Consortium of binding interactions

K4DD helps researchers to analyze kinetics to determine drug safety and efficacy early in the development process

QC for Alzheimer’s disease

QC for Alzheimer’s disease

Evotec collaborates with Probiodrug on glutaminyl cyclase (QC) inhibitors

Combating cancer across the pond

Combating cancer across the pond

Lorus, Cancer Research UK partner to advance solid tumor therapy to clinic

Taking it to the tumors

Taking it to the tumors

Ablynx and Algeta explore combination of thorium-227 alpha-pharmaceutical and Nanobody technology

Consortium of binding interactions

Consortium of binding interactions

K4DD helps researchers to analyze kinetics to determine drug safety and efficacy early in the development process

Government Watch

Second Circuit Court of Appeals rules on Caronia

Second Circuit Court of Appeals rules on Caronia

First Amendment protects free speech even when promoting misbranded, off-label drug use

Will FDA ‘reboot’ antibiotic approval process?

Will FDA ‘reboot’ antibiotic approval process?

At November hearing, FDA committee approves treatment for nosocomial pneumonia, sparking debate about agency’s approval of new antibiotics

Coming around again with gene patents

Coming around again with gene patents

Supreme Court to hear case challenging patents on breast and ovarian cancer genes

Research & Development

For the love of a child

For the love of a child

Shire, Boston Children’s Hospital partner on treatments for rare pediatric diseases

Sarepta Therapeutics, UCL partner on DMD drug target

Sarepta Therapeutics, UCL partner on DMD drug target

Sarepta Therapeutics announced last month a collaboration with University College London for the development of an exon-skipping drug targeting exon 53, its fourth drug in development, in support of Sarepta’s broad-based program for the treatment of Duchenne muscular dystrophy (DMD)

New CoMMpass bearings

New CoMMpass bearings

Landmark multiple myeloma study takes on Department of Veterans Affairs as valuable new public partner

Secondhand stem cell sale

Secondhand stem cell sale

Geron announces intent to sell discontinued stem cell programs to BioTime

What was old is new again

What was old is new again

Roche-Broad Institute collaboration aims to use modern platforms to find new indications for terminated development-stage compounds

Selecta, Sanofi partnership nothing to sneeze at

Selecta, Sanofi partnership nothing to sneeze at

Deal could total up to $300 million each for up to three candidates

Omics & Systems Biology

A game-changer in toxicity testing

A game-changer in toxicity testing

Hamner Institutes’ Integrated Biology Initiative aims to fundamentally transform chemical risk assessment

Tens, not thousands

Tens, not thousands

Planned Stanford genomics center receives final go-ahead

A ‘crucial’ partnership

A ‘crucial’ partnership

Empire Genomics, Emory University to develop multiple myeloma molecular diagnostic

Different genetic fingerprint

Different genetic fingerprint

Researchers study microbial DNA variation in the gut for clues to health

DNA2.0 partners with Newcastle U on B. subtillis system

DNA2.0 partners with Newcastle U on B. subtillis system

DNA2.0 last month announced a collaboration with Newcastle University to develop a protein expression system for Bacillus subtillis

Tools & Technology

Duet with ALK and FISH

Duet with ALK and FISH

Abbott Molecular adopts BioView’s Duet cell imaging software for its automated Vysis ALK FISH Probe test

Getting predictive with bioisosteres

Getting predictive with bioisosteres

Optibrium and Digital Chemistry announce technology collaboration to guide successful drug discovery

Getting PRO-ACTive about ALS

Getting PRO-ACTive about ALS

Prize4Life launches PRO-ACT ALS trials database

A new connection with Genection

A new connection with Genection

Invivoscribe launches new company to provide better, centralized genetic test offering

Making trials less of a trial

Making trials less of a trial

Janssen Research & Development announces establishment of databank to enhance global cross-pharmaceutical clinical trial efforts

Special Reports

No vaccine is an island

No vaccine is an island

Adjuvant advances, international interactions and personalized preventions are transforming the world of vaccinology

Commentary

The need for improved half-life extension technologies

The need for improved half-life extension technologies

In recent years, significant work has been dedicated to studying the half-life of drugs, and while researchers have been successful in lengthening the half-life of proteins and peptides, they have yet to find a way to tailor the pharmacokinetics of certain drugs to specific medical needs.”

Out of Order: Out of the Mayan pan

Out of Order: Out of the Mayan pan

For everyone’s sakes, we have to stay on the ball and be ready to jump in and lend a helping hand at any moment. The microbes don’t really care who we are or where we live.

Editor's Focus

Three resolutions to improve your business in ‘13

Three resolutions to improve your business in ‘13

If you want minimal results, resolve to do the bare minimum. If you want surprising results--results that set tongues to wagging and produce spikes in your stock price--you’ll need to think "outside of the box."
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

September 2022

Latest Issue  

• Volume 18 • Issue 9 • September 2022

September 2022

September 2022